Fig. 2From: Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancerKaplan–Meier curves for DFS (left) and OS (right) according to changes in SMI (increased, maintained, and decreased). DFS, HR 8.29; 95%CI 3.63–18.9; p < 0.001 for decreased vs. increased, HR 3.49; 95%CI 1.65–7.36; p < 0.001 decreased vs. maintained, HR 2.30; 95%CI 0.77–6.84; p = 0.15 maintained vs. increased. OS, HR 19.8; 95%CI 6.43–60.6; p < 0.001 for decreased vs. increased, HR 3.41; 95%CI 1.29–8.95; p = 0.013 decreased vs. maintained, HR 4.98; 95%CI 0.99–24.5; p = 0.11, maintained vs. increased). DFS: Disease-free survival, OS: Overall survival, SMI: Skeletal muscle index, NAC: Neoadjuvant chemotherapy, HR: Hazard ratio, CI: Confidence intervalBack to article page